Skip to main content
Top
Published in: BMC Nephrology 1/2014

Open Access 01-12-2014 | Research article

Actual versus ideal body weight for acute kidney injury diagnosis and classification in critically Ill patients

Authors: Charat Thongprayoon, Wisit Cheungpasitporn, Abbasali Akhoundi, Adil H Ahmed, Kianoush B Kashani

Published in: BMC Nephrology | Issue 1/2014

Login to get access

Abstract

Background

In the current acute kidney injury (AKI) definition, the urine output (UO) criterion does not specify which body weights (BW), i.e. actual (ABW) versus ideal (IBW), should be used to diagnose and stage AKI, leading to heterogeneity across research studies.

Methods

This is a single center, retrospective, observational study conducted at a tertiary referral hospital. All adult patients who were admitted to intensive care units (ICUs) at our institution for a minimum of 6 continuous hours between January and March 2010 and had a urinary catheter for hourly urine output monitoring were eligible for this study. Patients’ AKI stages, based on UO criterion, were assessed by calculating each milliliter of urine per kilogram per hour, using ABW versus IBW.

Results

A total of 493 ICU patients were included in the analysis. The median ABW and IBW were 82 (IQR 68-96) and 70 (IQR 60-77) kg, respectively. Using the IBW criterion, 154 patients (31.2%) were diagnosed with AKI, while 204 (41.4%) were diagnosed using the ABW measurement (P-value < .01). Patients who had AKI regardless of BW type had an adjusted odds ratio of 1.76 (95% CI 1.05-2.95) for 90-day mortality, whereas patients who had AKI according to ABW but not IBW had no significant increase in the risk of 90-day mortality, adjusted OR 0.76; (95% CI 0.25-1.91), compared to patients who had no AKI.

Conclusions

Using ABW to diagnose and stage AKI by UO criterion is more sensitive and less specific than IBW. Based on the application of the definition, different BW types could be utilized.
Appendix
Available only for authorised users
Literature
1.
go back to reference Srisawat N, Kellum JA: Acute kidney injury: definition, epidemiology, and outcome. Curr Opin Crit Care. 2011, 17 (6): 548-555. 10.1097/MCC.0b013e32834cd349.CrossRefPubMed Srisawat N, Kellum JA: Acute kidney injury: definition, epidemiology, and outcome. Curr Opin Crit Care. 2011, 17 (6): 548-555. 10.1097/MCC.0b013e32834cd349.CrossRefPubMed
2.
go back to reference Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005, 16 (11): 3365-3370. 10.1681/ASN.2004090740.CrossRefPubMed Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW: Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005, 16 (11): 3365-3370. 10.1681/ASN.2004090740.CrossRefPubMed
3.
go back to reference Ricci Z, Cruz D, Ronco C: The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int. 2008, 73 (5): 538-546. 10.1038/sj.ki.5002743.CrossRefPubMed Ricci Z, Cruz D, Ronco C: The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int. 2008, 73 (5): 538-546. 10.1038/sj.ki.5002743.CrossRefPubMed
4.
go back to reference Ricci Z, Cruz DN, Ronco C: Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol. 2011, 7 (4): 201-208. 10.1038/nrneph.2011.14.CrossRefPubMed Ricci Z, Cruz DN, Ronco C: Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol. 2011, 7 (4): 201-208. 10.1038/nrneph.2011.14.CrossRefPubMed
5.
go back to reference Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL: World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013, 8 (9): 1482-1493. 10.2215/CJN.00710113.CrossRefPubMedPubMedCentral Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL: World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013, 8 (9): 1482-1493. 10.2215/CJN.00710113.CrossRefPubMedPubMedCentral
6.
go back to reference Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007, 11 (2): R31-10.1186/cc5713.CrossRefPubMedPubMedCentral Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007, 11 (2): R31-10.1186/cc5713.CrossRefPubMedPubMedCentral
7.
go back to reference Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004, 8 (4): R204-212. 10.1186/cc2872.CrossRefPubMedPubMedCentral Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004, 8 (4): R204-212. 10.1186/cc2872.CrossRefPubMedPubMedCentral
8.
go back to reference Section 2: AKI Definition. Kidney inter, Suppl. 2012, 2 (1): 19-36. Section 2: AKI Definition. Kidney inter, Suppl. 2012, 2 (1): 19-36.
9.
go back to reference Macedo E, Malhotra R, Bouchard J, Wynn SK, Mehta RL: Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int. 2011, 80 (7): 760-767. 10.1038/ki.2011.150.CrossRefPubMed Macedo E, Malhotra R, Bouchard J, Wynn SK, Mehta RL: Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int. 2011, 80 (7): 760-767. 10.1038/ki.2011.150.CrossRefPubMed
10.
go back to reference Macedo E, Malhotra R, Claure-Del Granado R, Fedullo P, Mehta RL: Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2011, 26 (2): 509-515. 10.1093/ndt/gfq332.CrossRefPubMed Macedo E, Malhotra R, Claure-Del Granado R, Fedullo P, Mehta RL: Defining urine output criterion for acute kidney injury in critically ill patients. Nephrol Dial Transplant. 2011, 26 (2): 509-515. 10.1093/ndt/gfq332.CrossRefPubMed
11.
go back to reference Mehta RL: Acute kidney injury: Urine output in AKI–the canary in the coal mine?. Nat Rev Nephrol. 2013, 9 (10): 568-570. 10.1038/nrneph.2013.178.CrossRefPubMed Mehta RL: Acute kidney injury: Urine output in AKI–the canary in the coal mine?. Nat Rev Nephrol. 2013, 9 (10): 568-570. 10.1038/nrneph.2013.178.CrossRefPubMed
12.
go back to reference Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W: A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012, 27 (12): 4263-4272.CrossRefPubMedPubMedCentral Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen W: A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012, 27 (12): 4263-4272.CrossRefPubMedPubMedCentral
13.
go back to reference Group. KDIGOKAKIW: KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int. 2012, suppl 2 (1): 1-138. Group. KDIGOKAKIW: KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Kidney Int. 2012, suppl 2 (1): 1-138.
14.
go back to reference Devine BJ: Gentamicin therapy. Drug Intell Clin Pharm. 1974, 8: 650-655. Devine BJ: Gentamicin therapy. Drug Intell Clin Pharm. 1974, 8: 650-655.
15.
go back to reference Erstad BL: Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med. 2004, 30 (1): 18-32. 10.1007/s00134-003-2059-6.CrossRefPubMed Erstad BL: Dosing of medications in morbidly obese patients in the intensive care unit setting. Intensive Care Med. 2004, 30 (1): 18-32. 10.1007/s00134-003-2059-6.CrossRefPubMed
16.
go back to reference Pickering JW, Endre ZH: Back-Calculating Baseline Creatinine with MDRD Misclassifies Acute Kidney Injury in the Intensive Care Unit. Clin J Am Soc Nephrol. 2010, 5 (7): 1165-1173. 10.2215/CJN.08531109.CrossRefPubMedPubMedCentral Pickering JW, Endre ZH: Back-Calculating Baseline Creatinine with MDRD Misclassifies Acute Kidney Injury in the Intensive Care Unit. Clin J Am Soc Nephrol. 2010, 5 (7): 1165-1173. 10.2215/CJN.08531109.CrossRefPubMedPubMedCentral
17.
go back to reference Wentworth DN, Neaton JD, Rasmussen WL: An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health. 1983, 73 (11): 1270-1274. 10.2105/AJPH.73.11.1270.CrossRefPubMedPubMedCentral Wentworth DN, Neaton JD, Rasmussen WL: An evaluation of the Social Security Administration master beneficiary record file and the National Death Index in the ascertainment of vital status. Am J Public Health. 1983, 73 (11): 1270-1274. 10.2105/AJPH.73.11.1270.CrossRefPubMedPubMedCentral
18.
go back to reference Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA: RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006, 10 (3): R73-10.1186/cc4915.CrossRefPubMedPubMedCentral Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA: RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006, 10 (3): R73-10.1186/cc4915.CrossRefPubMedPubMedCentral
19.
go back to reference Coca SG, Peixoto AJ, Garg AX, Krumholz HM, Parikh CR: The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis. 2007, 50 (5): 712-720. 10.1053/j.ajkd.2007.07.018.CrossRefPubMed Coca SG, Peixoto AJ, Garg AX, Krumholz HM, Parikh CR: The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis. 2007, 50 (5): 712-720. 10.1053/j.ajkd.2007.07.018.CrossRefPubMed
20.
go back to reference Weisbord SD, Palevsky PM: Acute renal failure in the intensive care unit. Semin Respir Crit Care Med. 2006, 27 (3): 262-273. 10.1055/s-2006-945527.CrossRefPubMed Weisbord SD, Palevsky PM: Acute renal failure in the intensive care unit. Semin Respir Crit Care Med. 2006, 27 (3): 262-273. 10.1055/s-2006-945527.CrossRefPubMed
21.
go back to reference Lieske JC, Chawla L, Kashani K, Kellum JA, Koyner JL, Mehta RL: Biomarkers for acute kidney injury: where are we today? Where should we go?. Clin Chem. 2014, 60 (2): 294-300. 10.1373/clinchem.2012.201988.CrossRefPubMed Lieske JC, Chawla L, Kashani K, Kellum JA, Koyner JL, Mehta RL: Biomarkers for acute kidney injury: where are we today? Where should we go?. Clin Chem. 2014, 60 (2): 294-300. 10.1373/clinchem.2012.201988.CrossRefPubMed
22.
go back to reference Amundson DE, Djurkovic S, Matwiyoff GN: The obesity paradox. Crit Care Clin. 2010, 26 (4): 583-596. 10.1016/j.ccc.2010.06.004.CrossRefPubMed Amundson DE, Djurkovic S, Matwiyoff GN: The obesity paradox. Crit Care Clin. 2010, 26 (4): 583-596. 10.1016/j.ccc.2010.06.004.CrossRefPubMed
23.
go back to reference Druml W, Metnitz B, Schaden E, Bauer P, Metnitz PG: Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy. Intensive Care Med. 2010, 36 (7): 1221-1228. 10.1007/s00134-010-1844-2.CrossRefPubMed Druml W, Metnitz B, Schaden E, Bauer P, Metnitz PG: Impact of body mass on incidence and prognosis of acute kidney injury requiring renal replacement therapy. Intensive Care Med. 2010, 36 (7): 1221-1228. 10.1007/s00134-010-1844-2.CrossRefPubMed
Metadata
Title
Actual versus ideal body weight for acute kidney injury diagnosis and classification in critically Ill patients
Authors
Charat Thongprayoon
Wisit Cheungpasitporn
Abbasali Akhoundi
Adil H Ahmed
Kianoush B Kashani
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2014
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-15-176

Other articles of this Issue 1/2014

BMC Nephrology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.